Antimicrobial Agents and Chemotherapy
- Novel hydrazone compounds with broad-spectrum antiplasmodial activity and synergistic interactions with antimalarial drugs
- Ensuring a sustained workforce to combat antibiotic resistance in the 21st century: the critical need for training the next-gen of scientists at the pre-doctoral level
- Possibility of hypoalbuminemia itself as a risk for clinical failure
- Inactivation of the ribosome assembly factor RimP causes streptomycin resistance and impairs motility in Salmonellaby Zhihui LyuYunyi LingAmbro van HoofJiqiang Ling1Department of Cell Biology and Molecular Genetics, The University of Maryland, College Park, Maryland, USA2Department of Microbiology and Molecular Genetics, The University of Texas Health Science Center at Houston, Houston, Texas, USA on April 17, 2024 at 7:00 am
- Precise genome editing underlines the distinct contributions of mutations in ERG11, ERG3, MRR1, and TAC1 genes to antifungal resistance in Candida parapsilosis
- Correction for Chen et al., “Repurposing a human acetyl-CoA carboxylase inhibitor firsocostat to treat fungal candidiasis alone and in combination”by Tianyu ChenJing YaoKeao QuanJingchen XuXudong HangQian TongGenyan LiuPeipei LuoLiping ZengGanzhu FengHongkai Bi on April 16, 2024 at 7:00 am
- Genomic characterization of ST38 NDM-5-producing Escherichia coli isolates from an outbreak in the Czech Republic
- Combination of ganciclovir and trifluridine prevents drug-resistance emergence in HSV-1
- Effect modification of dosing strategy (AUC or trough) on AKI associated with vancomycin in combination with piperacillin/tazobactam or cefepime and meropenem
- Difficult-to-treat (DTR) Pseudomonas aeruginosa harboring Verona-Integron metallo-β-lactamase (blaVIM): infection management and molecular analysis
- Naphthylisoquinoline alkaloids: novel agents against the causative pathogens of eumycetoma and actinomycetoma—en route to broad-spectrum antimycetomal drugs
- Assessing potential drug-drug interactions between clofazimine and other frequently used agents to treat drug-resistant tuberculosis
- Comparison of lumefantrine, mefloquine, and piperaquine concentrations between capillary plasma and venous plasma samples in pregnant women with uncomplicated falciparum and vivax malaria
- Cefadroxil and cephalexin pharmacokinetics and pharmacodynamics in children with musculoskeletal infections
- The virtue of training: extending phage host spectra against vancomycin-resistant Enterococcus faecium strains using the Appelmans method
- Transcriptomic responses to antibiotic exposure in Mycobacterium tuberculosis
- Population pharmacokinetic modeling of dolutegravir/lamivudine to support a once-daily fixed-dose combination regimen in virologically suppressed adults living with HIV-1
- Extended blood stage sensitivity profiles of Plasmodium cynomolgi to doxycycline and tafenoquine, as a model for Plasmodium vivax
- Influenza C virus susceptibility to antivirals with different mechanisms of action
- Prospective validation of a model-informed precision dosing tool for vancomycin treatment in neonates